SF3B1 and neoplasm: Together, small molecules or antibodies (scFv) that inhibit FIRΔexon2 are candidates to suppress tumor metastasis and revealing the effects of FIR/FIRΔexon2/SAP155 complex to FBW7-related proteolysis are promising targets for future diagnostic and therapeutic applications.